All diabetes articles – Page 2
-
BusinessSensing the sweet spot
Ziylo’s selective glucose-binding molecule could open doors to smart insulin for diabetes
-
ResearchJelly implant keeps an eye on body oxygen levels
A soft hydrogel implant – the first of which has survived in the foot of its inventor for four years – could detect circulatory problems that end in amputations
-
ResearchGut bugs hijacking our signalling could treat disease
Gastrointestinal microflora found to produce a profusion of molecules that can affect human health
-
BusinessUniversity–industry collaborations aspire to pharmaceutical innovation
Three new UK partnerships illustrate drug research co-operation approaches that are growing in popularity
-
PodcastAdamantane
Brian Clegg introduces a crystalline hydrocarbon that isn’t as tough as it sounds, but is the basis of a wide range of medicines
-
BusinessNovo Nordisk to axe 1000 jobs
Diabetes specialist is cutting costs in the face of increased competition
-
BusinessSanofi sues Merck & Co over biosimilars
Merck challenges insulin patents, but Sanofi claims infringement
-
ResearchSweet tear sensor could ease pain of diabetes
New non-invasive sensor could check blood glucose levels using tears
-
Research
Phthalate replacements linked to child health problems
Levels of two plasticisers in children found to correlate with higher blood pressure and insulin resistance
-
Research'Smart patch' set to deliver for diabetes patients
Stick-on patch with glucose responsive microneedles releases insulin automatically whenever it is needed
-
Business
Takeda offers $2.4bn to settle diabetes litigation
Aims to settle multiple outstanding lawsuits relating to Actos (pioglitazone) and bladder cancer
-
-
ResearchSeeing glucose through the skin
Technique could one day allow diabetics to manage their condition without drawing blood
-
-
Business
Judge slashes fines in drug safety case
Takeda and Eli Lilly’s $9 billion damages in diabetes trial reduced to $38 million
-
Business
Sanofi snaps up inhaled insulin licence
Deal gives Mannkind access to global manufacturing and distribution for recently-approved Afrezza
-
BusinessPrice caps provoke lawsuits from Indian pharma industry
New government controls on cardiovascular and diabetes drugs challenged by industry lobby groups
-
Business
Inhaled insulin approved in US
European committee recommends approval for generic long-acting insulin
-
BusinessMissing safety risk emails draw $9bn Actos fine
Judge finds absence of Takeda documentation in bladder cancer case ‘disturbing’
-
Business
AstraZeneca shells out $4.1bn for diabetes business
Bristol-Myers Squibb exits the diabetes field with plans to become a specialised biopharmaceutical company
- Previous Page
- Page1
- Page2
- Page3
- Next Page